Clindamycin 150 Mg/Ml (4Ml Per Vial/Ampoule)

Terveyden ja hyvinvoinnin laitos Finland has Released a tender for Clindamycin 150 Mg/Ml (4Ml Per Vial/Ampoule) in Pharmaceuticals. The tender was released on Sep 23, 2025.

Country - Finland

Summary - Clindamycin 150 Mg/Ml (4Ml Per Vial/Ampoule)

Deadline - Oct 08, 2025

MT reference number - 118637078

Product classification - Antibacterials for systemic use

Organization Details:

  Address - Finland

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 118637078

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The acquisition focuses on Cllindamyc's 150 mg/ml (4 ml per Vial/ampoule) (later 'clindamycin'). This is a single acquisition and the product will be used by the Finnish Resceu Medical Warehouse. In addition to the estimated amount, THL has the right to purchase the product in addition to the estimated number ("option"). The total value of the acquisition is EUR 618,000, including options. The contracting entity acquires a medicinal product from a selected supplier as a direct procurement in accordance with the Procurement Act. In the previous open procedure, there are no bids at all and the original terms of the invitation to tender are not substantially changed.local title:: C

Mt Ref Id - 118637078

Deadline - Oct 08, 2025

Share

Similar Tenders :